samedan logo
 
 
spacer
home > white papers > Pharmaceutical Companies: Outsourcing Combination Product Manufacturing - Phillips-Medisize
WHITE PAPERS
logo_Phillips-Mk.jpg

Phillips-Medisize

phone +31 252 576 888
email eu_sales@phillipsmedisize.com
web http://www.phillipsmedisize.com
email Edisonstraat 1 Hillegom 2181 AB

Pharmaceutical Companies: Outsourcing Combination Product Manufacturing

Combination products are therapeutics that combine two or more products (drug/device, biologics/device, biologics/drugs, or drug/device/biologics), regulated and sold as a single unit. Examples of combination products include drug-coated implantable devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
Pharmaceutical Companies: Outsourcing Combination Product Manufacturing
spacer

Member login

E-mail address:

Password:
Remember me


News and Press Releases

Five methods for reducing pharmaceutical cargo theft

In North America, five percent of cargo thefts that occurred in 2020 were pharmaceutical products and 74 percent of all cargo theft occurred in transit, according to the BSI and TT Club Cargo Theft Report 2021. In the US and Canada, the biggest threat comes when containers or trailers are parked at insecure locations, as those were the most exploited vulnerabilities last year. Market dynamics also changed due to Covid-19, as demonstrated by the fact that the theft of stolen cargo in the form of medical supplies such as PPE, increased by more than 5,000 per cent in 2020, compared to 2019.
More info >>


White Papers

Data Technology as a Catalyst for Growth in the Life Sciences

Aigenpulse

The life sciences industry is changing at a rapid pace. The need to develop the next blockbuster is pushing current technologies and methodologies to the limit. Scientific advancement over the last decades was embossed with giant leaps in knowledge, however, the new reality is that smaller incremental gains need to be carved out with ever increasing investments. In order to survive, progress and prosper in this new reality, a holistic approach to getting the most of research data is crucial. In fact, it will likely be the difference of being in existence in 5-10 years or not. For those bold enough to step into an area they are unfamiliar with, huge rewards are waiting.
More info >>



©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement